Trial intelligence / Profile preview

Randomized study of Suboxone induction strategies in heroin users

2006-005235-14Phase 4Completed

Sponsor
Integrated Therapeutics Group
Start
Mar 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of Suboxone and buprenorphine in opioid use disorder (OUD) and substance use disorder (SUD) (2 arms), sponsored by Integrated Therapeutics Group. Primary endpoint: Response rate at Day 3. Started Mar 2007; status: completed.

02

Drugs

Suboxonebuprenorphine
03

Conditions

opioid use disorder (OUD)substance use disorder (SUD)

Beyond the preview

Go deeper on 2006-005235-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005235-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call